Potential of Apigenin, Berberine, Chrysin, and Luteolin to Overcome Doxorubicin Resistance in Acute Promyelocytic Leukemia HL-60 Cells
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262110565 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Piotr Wadowski und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland. Hauptthemen laut MEDLINE: Luteolin, Apigenin, Berberine, Doxorubicin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Multidrug resistance (MDR) is one of the leading causes of high mortality in cancer. The NRF2 (Nuclear Factor Erythroid 2-Related Factor 2) transcriptional factor can play a major role in MDR development. In this study, we tested the NRF2 inhibitors—Apigenin, Berberine, Chrysin, and Luteolin (ABCL) for their ability to overcome doxorubicin resistance in acute promyelocytic leukemia HL-60 cells (HL-60/DOXO cells). We examined the effects of NRF2 inhibitors on cell viability, apoptosis, DNA damage, and reactive oxygen species (ROS) generation. Our results indicate that Apigenin, Chrysin, and Luteolin can effectively overcome doxorubicin resistance in HL-60/DOXO cells. On the contrary, Berberine does not demonstrate this activity and even hinders doxorubicin’s activity. We hypothesize that the observed effects of ABCL may result from their interaction with the NRF2 factor, which is hyperactivated in the tested HL-60/DOXO cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.
- Doctoral School of Exact and Natural Sciences, University of Lodz, Banacha 12/16, 90-237 Lodz, Poland.
ORCID-Profile: Piotr Wadowski, Katarzyna Woźniak
Zitieren
APA
Wadowski, P., & Woźniak, K. (2025). Potential of Apigenin, Berberine, Chrysin, and Luteolin to Overcome Doxorubicin Resistance in Acute Promyelocytic Leukemia HL-60 Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110565
Vancouver
Wadowski P, Woźniak K. Potential of Apigenin, Berberine, Chrysin, and Luteolin to Overcome Doxorubicin Resistance in Acute Promyelocytic Leukemia HL-60 Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110565
BibTeX
@article{Wadowski2025,
author = {Wadowski, Piotr and Woźniak, Katarzyna},
title = {Potential of Apigenin, Berberine, Chrysin, and Luteolin to Overcome Doxorubicin Resistance in Acute Promyelocytic Leukemia HL-60 Cells},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262110565}
}
EUVIMED